Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes or is persistent, with at least one episode confirmed by a heart monitor or ECG recording within the past 24 months.
- You are between 18 and 80 years old.
- You are willing and able to sign a written consent form.
- You are able and willing to attend all required appointments and follow-up visits before, during, and after the trial.
Who may not be able to join:
- You have previously had surgery or a catheter-based procedure to treat atrial fibrillation.
- A scan taken within 48 hours before the procedure found a blood clot in the upper left chamber of your heart.
- You have severe, uncontrolled heart failure (the most serious level, where you experience symptoms even at rest).
- You have a history of blood clotting or bleeding problems, or you cannot safely take blood-thinning medications.
- You have a significant birth defect or other medical condition that the trial doctor believes would make participation unsafe (confirm with trial site).
- You have an implanted pacemaker, defibrillator, or other metal heart device that could interfere with the treatment used in this trial.
- You are pregnant, breastfeeding, or of childbearing age and planning to become pregnant during the trial.
- Your life expectancy is less than 12 months.
- You are currently taking part in another clinical trial involving a different device, treatment, or drug that could affect this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of early onset primary adverse events (PAEs); Freedom from documented atrial tachyarrhythmia episodes; Freedom from acute procedural failure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.